Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
BiDil: Assessing a race-based pharmaceutical
Howard Brody, Linda M. Hunt
Family Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
43
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'BiDil: Assessing a race-based pharmaceutical'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
drugs
100%
pharmaceuticals
100%
patients
60%
african americans
60%
populations
40%
diseases
20%
genetics
20%
doses
20%
ethnic groups
20%
availability
20%
income
20%
heart failure
20%
food and drug administration
20%
marketing
20%
Keyphrases
BiDil
100%
Welcome
20%
Underserved Groups
20%
Isosorbide
20%
Low-income Patients
20%
Generic Equivalent
20%
Medicine and Dentistry
Hydralazine Plus Isosorbide Dinitrate
100%
Isosorbide
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hydralazine Plus Isosorbide Dinitrate
100%
Isosorbide
20%